GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Distribution » Sichuan Goldstone Asia Pharmaceutical Inc (SZSE:300434) » Definitions » Shares Buyback Ratio %

Sichuan Goldstone Asia Pharmaceutical (SZSE:300434) Shares Buyback Ratio % : 0.00 (As of May. 23, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Sichuan Goldstone Asia Pharmaceutical Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Sichuan Goldstone Asia Pharmaceutical's current shares buyback ratio was 0.00%.


Sichuan Goldstone Asia Pharmaceutical Shares Buyback Ratio % Historical Data

The historical data trend for Sichuan Goldstone Asia Pharmaceutical's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sichuan Goldstone Asia Pharmaceutical Shares Buyback Ratio % Chart

Sichuan Goldstone Asia Pharmaceutical Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shares Buyback Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Sichuan Goldstone Asia Pharmaceutical Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Sichuan Goldstone Asia Pharmaceutical Shares Buyback Ratio % Calculation

Sichuan Goldstone Asia Pharmaceutical's Shares Buyback Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Dec. 2023 ) - Shares Outstanding (EOP) (A: Dec. 2024 )) / Shares Outstanding (EOP) (A: Dec. 2023 )
=(401.744 - 401.744) / 401.744
=0.00%

Sichuan Goldstone Asia Pharmaceutical's Shares Buyback Ratio for the quarter that ended in Mar. 2025 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Dec. 2024 ) - Shares Outstanding (EOP) (A: Mar. 2025 )) / Shares Outstanding (EOP) (A: Dec. 2024 )
=(401.744 - 401.744) / 401.744
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sichuan Goldstone Asia Pharmaceutical Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Sichuan Goldstone Asia Pharmaceutical's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sichuan Goldstone Asia Pharmaceutical Business Description

Traded in Other Exchanges
N/A
Address
8 Jiayuan Road, 8th Floor, District A1, Dadi Xinguanghua Plaza, Chengdu, CHN, 610072
Sichuan Goldstone Asia Pharmaceutical Inc is engaged in development and application of steel-reinforced plastic composite pipe technology, providing customers with steel-reinforced plastic composite pipes from pipe structure, production process to construction technology. The company is also engaged in research and development, production and sales of medicines and health products.
Executives
Zheng Zhi Yong Director
Wei Bao Kang Directors, executives
Kuai Yi Xi Director
Chen Shao Jiang Executives
Lai Xing Feng Supervisors
Lin Qiang Directors, Directors, and Executives
Fu Hai Ying Directors, executives
Wang Shou Lun Supervisors
Li Run Xiu Supervisors

Sichuan Goldstone Asia Pharmaceutical Headlines

No Headlines